Vimpat dry syrup 10%, containing Lacosamide, is manufactured by UCB Japan. Lacosamide is an antiepileptic drug used to treat partial-onset seizures in patients 1 month of age and older and as adjunctive therapy for primary generalized tonic-clonic seizures in patients 4 years of age and older. YJ code: 1139015R1023, Standard: 10%1g.
Vimpat dry syrup 10%
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
